Trinity Biotech TRIB
NASDAQ TRIB
$9.10 +0.09 (+1.00%)
As of: Sep 9, 2026 · 12:14 PM EDT

Trinity Biotech (TRIB) Amortization - Deferred Charges (2015 - 2016)

Trinity Biotech's (TRIB) quarterly Amortization - Deferred Charges came in at -$180000.0 in Q3 2016, up 13.46% year-over-year from -$158644.1 in Q4 2015, and down 0.56% quarter-over-quarter from -$179000.0 in Q2 2016.

Analysis

Trinity Biotech (TRIB) Amortization - Deferred Charges (2015 - 2016) Analysis & Trends

Trinity Biotech has disclosed Amortization - Deferred Charges across 2 years of filings, most recently posting -$180000.0 for Q3 2016.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortization - Deferred Charges (Qtr)
1 GE HealthCare Technologies 29.85 Bn 27.74 Bn 2.18 Bn -
2 Lantheus Holdings 6.57 Bn 5.98 Bn 241.86 Mn -
3 Heartflow 4.11 Bn 3.74 Bn 53.19 Mn -
4 Neogen 2.59 Bn 2.40 Bn 107.80 Mn -
5 Butterfly Network 1.99 Bn 1.87 Bn 23.29 Mn -
6 Ceribell 924.56 Mn 795.30 Mn 25.94 Mn -
7 QuidelOrtho 874.92 Mn 751.52 Mn - -
8 Varex Imaging 779.06 Mn 679.86 Mn 76.70 Mn -
9 Prenetics Global 340.90 Mn 281.85 Mn 30.20 Mn -
10 Trinity Biotech 5.79 Mn 5.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -180,000.00
Jun 30, 2016 -179,000.00
Sep 30, 2015 -208,000.00
Jun 30, 2015 -172,000.00